<code id='69D6F0969D'></code><style id='69D6F0969D'></style>
    • <acronym id='69D6F0969D'></acronym>
      <center id='69D6F0969D'><center id='69D6F0969D'><tfoot id='69D6F0969D'></tfoot></center><abbr id='69D6F0969D'><dir id='69D6F0969D'><tfoot id='69D6F0969D'></tfoot><noframes id='69D6F0969D'>

    • <optgroup id='69D6F0969D'><strike id='69D6F0969D'><sup id='69D6F0969D'></sup></strike><code id='69D6F0969D'></code></optgroup>
        1. <b id='69D6F0969D'><label id='69D6F0969D'><select id='69D6F0969D'><dt id='69D6F0969D'><span id='69D6F0969D'></span></dt></select></label></b><u id='69D6F0969D'></u>
          <i id='69D6F0969D'><strike id='69D6F0969D'><tt id='69D6F0969D'><pre id='69D6F0969D'></pre></tt></strike></i>

          explore

          explore

          author:comprehensive    Page View:45415

          What does Covid-19 have in store for the winter? When are good data not good enough? And how many would-be Wegovys are there?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Helen Branswell joins us to discuss the state of the Covid-19 pandemic heading into the fall and the rollout of boosters shots aimed at the latest viral variants. We also discuss the latest news in the life sciences, including an IPO implosion, a debate at the FDA, and the ups and downs of a career in biotech.

          advertisement

          For more on what we cover, here’s the latest on booster shots; here’s more on Covid-19 in 2023; here’s the news on Alnylam Pharmaceuticals; here’s more on 2Seventy Bio; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          comprehensive

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          AstraZeneca loses challenge to Medicare drug price negotiation
          AstraZeneca loses challenge to Medicare drug price negotiation

          ANDREWYATES/AFPviaGettyImagesWASHINGTON—AfederaljudgeinDelawareonFridayruledagainstAstraZenecainacas

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          Why does health care cost so much? A reading guide

          MikeReddyforSTATYou’rereadingthewebversionofHealthCareInc.,STAT’sweeklynewsletterfollowingtheflowofm